These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12515740)

  • 1. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.
    Grube E; Silber S; Hauptmann KE; Mueller R; Buellesfeld L; Gerckens U; Russell ME
    Circulation; 2003 Jan; 107(1):38-42. PubMed ID: 12515740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
    Tanabe K; Serruys PW; Grube E; Smits PC; Selbach G; van der Giessen WJ; Staberock M; de Feyter P; Müller R; Regar E; Degertekin M; Ligthart JM; Disco C; Backx B; Russell ME
    Circulation; 2003 Feb; 107(4):559-64. PubMed ID: 12566366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    Circulation; 2004 Apr; 109(16):1942-7. PubMed ID: 15078803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
    Colombo A; Drzewiecki J; Banning A; Grube E; Hauptmann K; Silber S; Dudek D; Fort S; Schiele F; Zmudka K; Guagliumi G; Russell ME;
    Circulation; 2003 Aug; 108(7):788-94. PubMed ID: 12900339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
    Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions.
    Waugh J; Wagstaff AJ
    Am J Cardiovasc Drugs; 2004; 4(4):257-68. PubMed ID: 15285700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
    Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
    Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
    Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial.
    Kereiakes DJ; Cannon LA; Feldman RL; Popma JJ; Magorien R; Whitbourn R; Dauber IM; Rabinowitz AC; Ball MW; Bertolet B; Kabour A; Foster MC; Wang JC; Underwood P; Dawkins KD
    J Am Coll Cardiol; 2010 Jul; 56(4):264-71. PubMed ID: 20493653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-eluting stents: current clinical experience.
    Grube E; Buellesfeld L
    Am J Cardiovasc Drugs; 2004; 4(6):355-60. PubMed ID: 15554720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
    Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
    Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
    Grube E; Schofer J; Hauptmann KE; Nickenig G; Curzen N; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2010 Apr; 3(4):431-8. PubMed ID: 20398872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.